Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_assertion type Assertion NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_head.
- NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_assertion description "[ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_provenance.
- NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_assertion evidence source_evidence_literature NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_provenance.
- NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_assertion SIO_000772 15867198 NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_provenance.
- NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_assertion wasDerivedFrom befree-2016 NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_provenance.
- NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_assertion wasGeneratedBy ECO_0000203 NP492673.RAPkAHtC8HEbb4Ygv2HjDAWmizouk9hcoO7ii3BXpC3Yo130_provenance.